Atropine sulfate 19.4 mcg / hyoscyamine sulfate 103.7 mcg / scopolamine HBr 6.5 mcg Oral Tablet
RxNorm 1048078
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1048078 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: atropine sulfate 19.4 mcg / hyoscyamine sulfate 103.7 mcg / scopolamine HBr 6.5 mcg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Atropine sulfate 0.0194 mg / hyoscyamine sulfate 0.1037 mg / scopolamine hydrobromide 0.0065 mg Oral Tablet
(Atom ID: 12346706)
PSN
Prescribable Name (PSN):
Atropine sulfate 19.4 mcg / hyoscyamine sulfate 103.7 mcg / scopolamine HBr 6.5 mcg Oral Tablet
(Atom ID: 6371964)
SY
Synonym (SY):
Atropine sulfate 19.4 mcg / hyoscyamine sulfate 103.7 mcg / scopolamine hydrobromide 6.5 mcg Oral Tablet
(Atom ID: 3521841)
SY
Synonym (SY):
Atropine sulfate 19.4 microgram and hyoscine hydrobromide 6.5 microgram and hyoscyamine sulfate 103.7 microgram oral tablet
(Atom ID: 10294515)
PT
Designated preferred name (PT):
Atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram oral tablet
(Atom ID: 10294516)
FN